股票/基金 实时行情 股吧

简称:太龙药业 代码:600222


会计年度:2019-12-31收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,311,192,274.62826,506,791.56484,685,483.0636.97
药品研发服务224,318,388.60115,435,098.78108,883,289.8248.54
药品药材流通91,400,625.0084,149,617.157,251,007.857.93
药品制造995,473,261.02626,922,075.64368,551,185.3837.02

会计年度:2018-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,191,474,619.23790,306,864.29401,167,754.9433.67
药品研发服务188,399,406.6995,646,306.1592,753,100.5449.23
药品药材流通194,802,887.85175,456,269.1819,346,618.679.93
医药制造808,272,324.69519,204,288.96289,068,035.7335.76

会计年度:2017-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计1,166,180,438.78811,854,846.41354,325,592.3730.38
药品流通311,484,635.00261,642,033.5949,842,601.4116.00
药品研发服务123,898,283.2941,774,892.4682,123,390.8366.28
药品制造730,797,520.49508,437,920.36222,359,600.1330.43

会计年度:2017-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
分部间抵销3,514.463,499.4315.030.43
技术研发4,482.121,436.563,045.5667.95
医药流通13,212.9010,763.182,449.7218.54
医药制造35,000.2825,911.689,088.6025.97

会计年度:2016-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
其他12,130,528.438,382,289.163,748,239.2730.90
药品研发服务92,682,617.4027,278,945.0465,403,672.3670.57
医药流通194,551,126.40174,664,564.1319,886,562.2710.22
医药制造650,717,411.15432,505,118.68218,212,292.4733.53

    1/7 转到